| 目录号 | 品名 | CAS号 | 描述 | 详情 |
|---|---|---|---|---|
| HD01078 | ApreMilast | 608141-41-9 | PDE4 inhibitor | |
| HD01079 | Selexipag | 475086-01-2 | prostacyclin IP1 receptor agonist | |
| HD01076 | Rivaroxaban | 366789-02-8 | ||
| HD01077 | Tofacitinib | 477600-75-2 | Janus kinase inhibitor | |
| HD01074 | Vonoprazan | 881681-00-1 | Vonoprazan is an orally active potassium-competitive acid blocker which inhibits H+, K+-ATPase activity | |
| HD01075 | Febuxostat | 144060-53-7 | non-purine selective inhibitor of xanthine oxidase | |
| HD01071 | Ozenoxacin | 245765-41-7 | ||
| HD01072 | R-(+)-Lansoprazole | 138530-94-6 | Lansoprazole(AG 1749) is a proton pump inhibitor which prevents the stomach from producing acid. | |
| HD01073 | (+)-(R)-Pantoprazole | 160098-11-3 | ||
| HD01069 | Linagliptin | 668270-12-0 | DDP-4 inhibitor,highly potent and competitive | |
| HD01070 | Linezolid | 165800-03-3 | ||
| HD01067 | Pioglitazone | 1266523-09-4 | Pioglitazone is an agonist of the peroxisome proliferator-activated receptor γ | |
| HD01068 | Repaglinide | 135062-02-1 | Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus | |
| HD01065 | Trelagliptin succinate | 1029877-94-8 | Trelagliptin is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D). | |
| HD01066 | Canagliflozin | 842133-18-0 | Canagliflozin is a novel, potent, and highly selective sodium glucose co-transporter (SGLT) 2 inhibitor | |
| HD01063 | Compactin | 73573-88-3 | ||
| HD01064 | Empagliflozin | 864070-44-0 | Empagliflozin (BI 107730 is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2 | |
| HD01051 | Cladosporin | 35818-31-6 | ||
| HD01052 | Clarithromycin | 81103-11-9 | ||
| HD01049 | Cladosporide C | 376368-82-0 |
您是第 2847370 位访问者
电话：0086-571-89903882
邮箱：hdcsales@huidacollection.cn
Copyright © 2021 浙江珲达生物科技有限公司
浙ICP备20008217-2号
Designed by Wanhu 
公安备案号 33010502006723